Aelis Farma (FRA:69O) Institutional Ownership: 0.11% (As of Aug. 07, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:69O Aelis Farma SA FRA:69O
29 GF Score
Price €1.00
GF Value €0.94
! 4 Warning Signs
View Full Analysis

What is Aelis Farma Institutional Ownership?

Aelis Farma FRA:69O +1.94% 29 Institutional Ownership is 0.11% as of Aug. 07, 2026. GuruFocus rates FRA:69O with a GF Score™ of 29/100 and a GF Value™ of €0.94. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aelis Farma's institutional ownership is 0.11%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aelis Farma's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aelis Farma's Float Percentage Of Total Shares Outstanding is 0.00%.

Aelis Farma Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Aelis Farma's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aelis Farma Institutional Ownership Chart

Aelis Farma Historical Data

The historical data trend for Aelis Farma can be seen below:

2024-10-31 2024-11-30 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30 2025-05-31 2025-06-30 2025-07-31
Institutional Ownership 0.40 0.34 0.74 0.58 0.38 0.31 0.27 0.20 0.16 0.11
FRA:69O
29GF Score
Aelis Farma SA FRA:69O
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aelis Farma Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.11% mean?
Aelis Farma (FRA:69O) has a Institutional Ownership of 0.11% as of Aug. 07, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Aelis Farma and its competitors.
Is Aelis Farma's Institutional Ownership too high?
Aelis Farma's current Institutional Ownership is 0.11%. Overall, Aelis Farma has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Aelis Farma's Institutional Ownership compare to VRTX and REGN?
Aelis Farma's Institutional Ownership of 0.11% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Aelis Farma and its competitors. Aelis Farma's current Institutional Ownership is 0.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aelis Farma stock overvalued right now?
Aelis Farma (FRA:69O) has a current Institutional Ownership of 0.11%. The stock's GF Value™ is €0.94, compared to a current price of €1.00 — trading 6.1% above its estimated fair value. The current Institutional Ownership is 0.11%. Aelis Farma's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Aelis Farma (FRA:69O), the current Institutional Ownership is 0.11% as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aelis Farma (FRA:69O) Overvalued in 2026?

Based on GuruFocus' analysis, Aelis Farma stock appears to be overvalued. The current stock price of €1.00 is trading 6.1% above its estimated GF Value™ of €0.94.

Key valuation signals for FRA:69O:

  • Institutional Ownership: 0.11%
  • GF Value™: €0.94 vs. price of €1.00 (6.1% above fair value)
  • GF Score™: 29/100 with 4 warning signs

No single metric tells the full story. See the FRA:69O stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aelis Farma Business Description

Other Exchanges AELIS:France
Address 2 rue Robert Escarpit, IECB, Pessac, Bordeaux, FRA, 33607
Aelis Farma SA is a biotechnology Company specializing in the research and development of treatment's related to brain diseases. The Company operates in only one business segment: the research and development of pharmaceutical products.
29GF Score

Get the complete analysis for FRA:69O

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.00
Price
€0.94
GF Value